- Trials with a EudraCT protocol (13)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (9)
13 result(s) found for: Hyperuricemia.
Displaying page 1 of 1.
EudraCT Number: 2014-003989-24 | Sponsor Protocol Number: L_9436 | Start Date*: 2014-12-19 | |||||||||||
Sponsor Name:Sanofi | |||||||||||||
Full Title: Program of Rasburicase in the Treatment of Hyperuricemia in Children and Adolescent Patients With or at Risk of Tumor Lysis Syndrome | |||||||||||||
Medical condition: Hyperuricemia | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: Outside EU/EEA | |||||||||||||
Trial results: View results |
EudraCT Number: 2021-003176-14 | Sponsor Protocol Number: LPS15679 | Start Date*: 2021-06-29 | |||||||||||
Sponsor Name:Sanofi-Aventis Groupe | |||||||||||||
Full Title: An Open-label, Single-arm, Multi-center Study to Evaluate the Efficacy and Safety of Rasburicase (Fasturtec®) in the Prevention and Treatment of Hyperuricemia in Pediatric Patients with Non-Hodgkin... | |||||||||||||
Medical condition: Hyperuricemia | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: Outside EU/EEA | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-001858-25 | Sponsor Protocol Number: MEIN/11/FEB-GOU/001 | Start Date*: 2013-01-28 | ||||||||||||||||
Sponsor Name:MENARINI INTERNATIONAL OPERATIONS LUXEMBOURG S.A. | ||||||||||||||||||
Full Title: A multicentre, randomised, double-blind, parallel group study on the therapeutic efficacy and safety of Febuxostat (taken once daily) and the therapeutic efficacy and safety of Allopurinol on serum... | ||||||||||||||||||
Medical condition: hyperuricemia and gout | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: GR (Completed) IT (Completed) ES (Completed) BG (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2012-002662-12 | Sponsor Protocol Number: PSY102 | Start Date*: 2012-12-12 | |||||||||||
Sponsor Name:Psyadon Pharmaceuticals Inc. | |||||||||||||
Full Title: An Outpatient Phase 3 Efficacy Study of Ecopipam (PSYRX 101) in the Symptomatic Treatment of Self-Injurious Behavior in Subjects with Lesch-Nyhan Disease (LND). | |||||||||||||
Medical condition: Self-injurious behavior in subjects with Lesch-Nyhan Disease (LND). | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) NL (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-006994-10 | Sponsor Protocol Number: SEQ-ALO-2007-01 | Start Date*: 2009-02-04 | ||||||||||||||||
Sponsor Name:Fundación Investigación Biomédica Hospital Príncipe de Asturias | ||||||||||||||||||
Full Title: Evaluación de la utilidad del alopurinol en la prevención de la morbimortalidad cardiovascular de los pacientes con enfermedad renal crónica (ERC) e hiperuricemia EVALUATION OF THE USE OF ALLOPURI... | ||||||||||||||||||
Medical condition: Enfermedad renal crónica (ERC) e hiperuricemia | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: ES (Prematurely Ended) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-014762-26 | Sponsor Protocol Number: RDEA594-204 | Start Date*: 2009-10-27 | |||||||||||
Sponsor Name:Ardea Biosciences, Inc. | |||||||||||||
Full Title: A Phase 2, Multiple-Dose, Pharmacokinetic and Pharmacodynamic Study of RDEA594 in Gout Patients with Hyperuricemia and Gout with Renal Insufficiency | |||||||||||||
Medical condition: Gout. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2022-003573-32 | Sponsor Protocol Number: 2022/ABM/01/00027 | Start Date*: 2023-12-28 | |||||||||||||||||||||||||||||||||||||||||
Sponsor Name:Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu | |||||||||||||||||||||||||||||||||||||||||||
Full Title: A randomized, double-blind, placebo-controlled study to evaluate the effect of allopurinol on the risk of cardiovascular events in patients at high and very high cardiovascular risk, including the ... | |||||||||||||||||||||||||||||||||||||||||||
Medical condition: hyperuricemia, hypertension, ischemic stroke, intracerebral haemorrhage, TIA, heart failure, peripheral arterial disease, atrial fibrillation, diabetes mellitus | |||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||||||||||||||||||||||
Trial protocol: PL (Trial now transitioned) | |||||||||||||||||||||||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-001640-56 | Sponsor Protocol Number: PI12/01866 | Start Date*: 2014-01-31 | |||||||||||
Sponsor Name:Fundación Para la Investigación Biomédica de Córdoba | |||||||||||||
Full Title: Crossover clinical trial, randomized, double blind, placebo controlled trial. Modulation of cellular mediators and repair endothelial damage in patients with chronic renal disease through inhibitio... | |||||||||||||
Medical condition: Patients with chronic kidney disease and asymptomatic hyperuricemia on the balance of mechanisms of vascular injury and repair. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-013055-30 | Sponsor Protocol Number: RDEA594-202 | Start Date*: 2009-08-30 | |||||||||||
Sponsor Name:Ardea Biosciences, Inc. | |||||||||||||
Full Title: Randomized, Double-Blind, Multicenter, Placebo-Controlled, Safety and Efficacy Study of RDEA594 Versus Placebo in the Treatment of Hyperuricemia in Patients with Gout Estudio Multicéntrico, Aleat... | |||||||||||||
Medical condition: Gout / Gota | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) DE (Completed) GB (Prematurely Ended) CZ (Completed) BG (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2020-005721-82 | Sponsor Protocol Number: NL74873.091.20 | Start Date*: 2021-02-08 |
Sponsor Name:VieCuri | ||
Full Title: The Gout TrEatment STrategy Project (GO TEST) Overture trial | ||
Medical condition: gout | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2011-002453-65 | Sponsor Protocol Number: ALLO-401 | Start Date*: 2012-01-18 | |||||||||||
Sponsor Name:Ardea Biosciences, Inc. | |||||||||||||
Full Title: Long-term Allopurinol Safety Study Evaluating Outcomes in Gout Patients (LASSO) | |||||||||||||
Medical condition: Gout | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) BE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-005567-33 | Sponsor Protocol Number: MEIN/14/FEB-PWV/001 | Start Date*: 2015-09-11 | |||||||||||
Sponsor Name:Menarini International Operations Luxembourg S.A. | |||||||||||||
Full Title: The Effect of Intensive Urate Lowering Therapy (ULT) with Febuxostat in Comparison with Allopurinol on Cardiovascular Risk in Patients with Gout Using Surrogate Markers: a Randomized, Controlled Tr... | |||||||||||||
Medical condition: Gout | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Completed) DE (Completed) PL (Completed) HR (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-014660-19 | Sponsor Protocol Number: RDEA594-203 | Start Date*: 2009-12-09 | |||||||||||
Sponsor Name:Ardea Biosciences, Inc. | |||||||||||||
Full Title: Randomized, Double-Blind, Multicenter, Placebo-Controlled, Combination Study to Evaluate the Safety, Efficacy and Potential Pharmacokinetic Interaction of RDEA594 and Allopurinol in Gout Patients w... | |||||||||||||
Medical condition: Gout | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) ES (Completed) PL (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
